A new era
We are delighted that Northern Sydney Local Health District is ushering in a transformative new era in research through clinical trials. Clinical trials are the bedrock of medical innovation, providing our patients with access to the latest treatments and therapies. They pave the way for tomorrow’s medicines and are crucial in advancing medical science.
For decades, our district has been home to world-leading clinical investigators conducting research that has changed medical practice, not only locally but also globally. Having witnessed firsthand the extraordinary impact clinical trials can have on patient outcomes, we have long seen their essential role in advancing medical science. Through these trials, we have seen lives transformed and patients receive cutting-edge care that significantly improves their health and quality of life. Our new vision for the district is to offer every patient the opportunity to participate in a clinical trial. By integrating clinical trials into our standard patient care protocols, we can ensure that all patients benefit from the latest medical innovations. This approach will enhance current patient care and set the stage for ongoing medical breakthroughs. A key factor in achieving this vision is robust philanthropic support. Generous contributions from individuals, foundations, and corporations are vital to funding these trials. By investing in clinical trials, donors directly contribute to medical discoveries and improved patient outcomes. We urge everyone in our community to consider how they can support and advocate for this crucial initiative. Together, we can create a healthcare environment where every patient has access to the most advanced treatments and where continuous innovation is the norm.
This publication, Tomorrow’s medicine today , highlights our incredible clinical trial work and celebrates the researchers and clinicians whose passion drives this innovative research. Scientific discovery is not easy and requires the dedication of both professionals and patients. We both want to thank all involved in advancing medical science and patient care. Your support in researching or participating in clinical trials will make a significant difference to the lives of people in our community and the future of healthcare. This is an exciting chapter for our district as we continue to prioritise and elevate our research initiatives. Adjunct Professor Anthony M. Schembri AM Chief Executive NSLHD Nadia Levin Chair of the NSLHD Research, Innovation and Technology Committee
Nadia Levin and Adjunct Professor Anthony M. Schembri AM
3
Made with FlippingBook - professional solution for displaying marketing and sales documents online